chronic obstructive pulmonary disease

What providers need to do to improve chronic careA West survey finds that an overwhelming number of chronic care patients say they need help managing their disease.
Study finds hike in pneumonia for COPD patients receiving corticosteroidsComorbid CVD is an independent risk factor for CAP in patients with COPD. And inhaled steroids may increase CAP risk.
A Triple Hitter in One Blast: COPD Lessons from TRILOGYPatients with severe COPD are likely to suffer frequent disease exacerbations and a reduced quality of life.
QD Fluticasone-Vilanterol combo reduces COPD exacerbationsIn patients with COPD who have a history of exacerbations, a once-daily treatment regimen of combined fluticasone furoate and vilanterol was associated with fewer exacerbations than usual care without a greater risk of serious adverse events
COPD and pharmacotherapy for smoking cessation at the VA: StudyUse of tobacco-cessation therapy was low. The study found several negative factors — and two positive predictors.
Umeclidinium triple therapy for patients with COPD: Two studiesBoth studies demonstrated statistical improvements in trough FEV1 at day 85.
FDA approves new COPD treatmentsFDA approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) and the stand-alone monotherapy Seebri Neohaler (glycopyrrolate) – which is one component of Utibron Neohaler -- for patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Benzodiazepine use in older COPD patients may not be idealBenzodiazepine use in COPD patients linked to increased exacerbation, according to study out of Canada.
Health apps beneficial to help prevent COPD exacerbationA new report indicates the successes of early interventions through digital health applications to help manage COPD.
Partnering on COPD for savings, outcomesA leading pharmaceutical company is partnering with payers to help lower COPD complications.